SCHEMBL20725570

SCHEMBL20725570

CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4CC(N)=O)n3)c(O)c2)CC1

nearest known ligand 0.87

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.87
▸ FLT4 P35916 7/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14635552 0.93 PTK2 (1.00) PTK2FLT4
SCHEMBL14635844 0.93 PTK2 (1.00) PTK2FLT4
SCHEMBL12479033 0.93 PTK2 (1.00) PTK2FLT4
Narmafotinib SCHEMBL12479576 0.91 PTK2 (1.00) PTK2FLT4
Narmafotinib SCHEMBL30354504 0.91 PTK2 (1.00) PTK2FLT4
SCHEMBL14635846 0.90 PTK2 (1.00) PTK2FLT4
SCHEMBL14576624 0.88 PTK2 (1.00) PTK2FLT4
SCHEMBL14635541 0.86 PTK2 (0.86) PTK2FLT4
SCHEMBL12478590 0.84 PTK2 (0.85) PTK2FLT4
SCHEMBL12478577 0.84 PTK2 (0.85) PTK2FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675794-B1 SELECTIVE FAK INHIBITORS CANCER THERAPEUTICS CRC PTY LTD (AU) 2019-02-13 — — EP disclosed
Send feedback